Respiratory Health Association plays an important role in research. Unfortunately, lung disease research is underfunded, slowing gains in knowledge, diagnosis and treatment progress. RHA actively works to address this by supporting clinical trial studies, participating in research collaborations, and funding innovative lung health research.

If you’d like to help fund RHA’s research efforts, contact Joel Africk, President and Chief Executive Officer, via email at [email protected] or by phone at (312) 628-0220.

Clinical Trials

RHA engages with community partners to support lung health research trials. These clinical trial studies are designed to determine the safety and effectiveness of new medications, medical devices or other treatment options.


RHA participates in community-centered research that aims to improve outcomes for children and adults living with lung disease.

RHA Funding Opportunities

RHA funds ground-breaking lung disease research at major institutions in metropolitan Chicago. These grants are designed to aid local scientists/investigators in generating the preliminary data necessary to compete for future federal funding.

Regulatory Compliance Disclosure

RHA expects all of its employees, volunteers, researchers, vendors, affiliates of any kind, and any other person or entity with whom it works to conduct themselves with the highest possible integrity, and to support its mission through the ethical conduct of research.

The following policies have been developed to be in compliance with regulations for all Public Health Service-sponsored Research:

RHA’s Financial Conflict of Interest Policy is drafted in accordance with the guidelines set forth in 42 C.F.R. § 50, Subpart F and is intended to comply with all requirements of the Regulations.

For inquiries about these policies, please email [email protected].